Saturday 27 February 2010

Zolacos




Zolacos may be available in the countries listed below.


Ingredient matches for Zolacos



Bicalutamide

Bicalutamide is reported as an ingredient of Zolacos in the following countries:


  • Australia

International Drug Name Search

Oftacilox




Oftacilox may be available in the countries listed below.


Ingredient matches for Oftacilox



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Oftacilox in the following countries:


  • Italy

  • Portugal

  • Spain

International Drug Name Search

Thursday 25 February 2010

Doxycyclin-ratiopharm




Doxycyclin-ratiopharm may be available in the countries listed below.


Ingredient matches for Doxycyclin-ratiopharm



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin-ratiopharm in the following countries:


  • Germany

  • Luxembourg

International Drug Name Search

Sunday 21 February 2010

Apo Clopidogrel




Apo Clopidogrel may be available in the countries listed below.


Ingredient matches for Apo Clopidogrel



Clopidogrel

Clopidogrel is reported as an ingredient of Apo Clopidogrel in the following countries:


  • Singapore

Clopidogrel hydrogen sulfate (a derivative of Clopidogrel) is reported as an ingredient of Apo Clopidogrel in the following countries:


  • New Zealand

International Drug Name Search

Wednesday 17 February 2010

Vertel




Vertel may be available in the countries listed below.


Ingredient matches for Vertel



Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Vertel in the following countries:


  • Portugal

International Drug Name Search

Tuesday 16 February 2010

Merrem


Merrem is a brand name of meropenem, approved by the FDA in the following formulation(s):


MERREM (meropenem - injectable; injection)



  • Manufacturer: ASTRAZENECA

    Approval date: June 21, 1996

    Strength(s): 1GM/VIAL [RLD][AP], 500MG/VIAL [RLD][AP]

Has a generic version of Merrem been approved?


Yes. The following products are equivalent to Merrem:


meropenem injectable; injection



  • Manufacturer: ACS DOBFAR

    Approval date: October 26, 2011

    Strength(s): 1GM/VIAL [AP], 500MG/VIAL [AP]


  • Manufacturer: HOSPIRA INC

    Approval date: June 22, 2010

    Strength(s): 1GM/VIAL [AP], 500MG/VIAL [AP]


  • Manufacturer: SANDOZ

    Approval date: March 29, 2011

    Strength(s): 1GM/VIAL [AP], 500MG/VIAL [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Merrem. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Merrem.

See also...

  • Merrem Consumer Information (Drugs.com)
  • Merrem Consumer Information (Wolters Kluwer)
  • Merrem Consumer Information (Cerner Multum)
  • Merrem AHFS DI Monographs (ASHP)
  • Meropenem Consumer Information (Wolters Kluwer)
  • Meropenem Consumer Information (Cerner Multum)
  • Merrem IV Advanced Consumer Information (Micromedex)
  • Meropenem Intravenous Advanced Consumer Information (Micromedex)
  • Meropenem AHFS DI Monographs (ASHP)

Sunday 14 February 2010

Pentoxicux




Pentoxicux may be available in the countries listed below.


Ingredient matches for Pentoxicux



Pentoxifylline

Pentoxifylline is reported as an ingredient of Pentoxicux in the following countries:


  • Germany

International Drug Name Search

Aceprom




Aceprom may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Aceprom



Acepromazine

Acepromazine maleate (a derivative of Acepromazine) is reported as an ingredient of Aceprom in the following countries:


  • Netherlands

  • South Africa

International Drug Name Search

Monday 8 February 2010

Zolinza




In the US, Zolinza (vorinostat systemic) is a member of the drug class histone deacetylase inhibitors and is used to treat Cutaneous T-cell Lymphoma.

US matches:

  • Zolinza

Ingredient matches for Zolinza



Vorinostat

Vorinostat is reported as an ingredient of Zolinza in the following countries:


  • United States

International Drug Name Search

Zantic 75




Zantic 75 may be available in the countries listed below.


Ingredient matches for Zantic 75



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Zantic 75 in the following countries:


  • Switzerland

International Drug Name Search

Saturday 6 February 2010

Zovir




Zovir may be available in the countries listed below.


Ingredient matches for Zovir



Acyclovir

Aciclovir is reported as an ingredient of Zovir in the following countries:


  • Denmark

  • Iceland

Aciclovir sodium salt (a derivative of Aciclovir) is reported as an ingredient of Zovir in the following countries:


  • Iceland

International Drug Name Search

Thursday 4 February 2010

Acido clavulanico




Acido clavulanico may be available in the countries listed below.


Ingredient matches for Acido clavulanico



Clavulanate

Acido clavulanico (DCIT) is known as Clavulanate in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Oxedrine Tartrate




Oxedrine Tartrate may be available in the countries listed below.


Ingredient matches for Oxedrine Tartrate



Oxedrine

Oxedrine Tartrate (BANM) is also known as Oxedrine (BAN)

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 3 February 2010

Reducid




Reducid may be available in the countries listed below.


Ingredient matches for Reducid



Ranitidine

Ranitidine is reported as an ingredient of Reducid in the following countries:


  • Ethiopia

International Drug Name Search

Tuesday 2 February 2010

bivalirudin Intravenous


bye-VAL-i-roo-din


Commonly used brand name(s)

In the U.S.


  • Angiomax

Available Dosage Forms:


  • Powder for Solution

Therapeutic Class: Anticoagulant


Pharmacologic Class: Thrombin Inhibitor, Direct


Chemical Class: Hirudin Related


Uses For bivalirudin


Bivalirudin is used together with aspirin to decrease the clotting ability of the blood and to help prevent harmful clots from forming in the blood vessels. It is used in patients who are having certain heart and blood vessel procedures, such as coronary angioplasty.


bivalirudin is available only with your doctor's prescription.


Before Using bivalirudin


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bivalirudin, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to bivalirudin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of bivalirudin in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of bivalirudin in the elderly. However, elderly patients are more likely to have bleeding problems than younger adults, which may require caution in patients receiving bivalirudin.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving bivalirudin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using bivalirudin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abciximab

  • Acenocoumarol

  • Alteplase, Recombinant

  • Anistreplase

  • Argatroban

  • Bromfenac

  • Celecoxib

  • Chamomile

  • Citalopram

  • Clopidogrel

  • Dabigatran Etexilate

  • Dalteparin

  • Danaparoid

  • Desvenlafaxine

  • Diclofenac

  • Diflunisal

  • Dipyridamole

  • Drotrecogin Alfa

  • Enoxaparin

  • Eptifibatide

  • Escitalopram

  • Etodolac

  • Fluoxetine

  • Flurbiprofen

  • Fluvoxamine

  • Fondaparinux

  • Garlic

  • Ginkgo

  • Heparin

  • Ibuprofen

  • Ibuprofen Lysine

  • Indomethacin

  • Ketoprofen

  • Ketorolac

  • Lepirudin

  • Magnesium Salicylate

  • Mefenamic Acid

  • Meloxicam

  • Milnacipran

  • Nabumetone

  • Naproxen

  • Nepafenac

  • Oxaprozin

  • Papaya

  • Paroxetine

  • Phenindione

  • Phenprocoumon

  • Piroxicam

  • Reteplase, Recombinant

  • Rivaroxaban

  • Salsalate

  • Sertraline

  • St John's Wort

  • Streptokinase

  • Sulindac

  • Tan-Shen

  • Tenecteplase

  • Ticlopidine

  • Tinzaparin

  • Tirofiban

  • Tolmetin

  • Urokinase

  • Venlafaxine

  • Warfarin

Using bivalirudin with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Avocado

  • Chondroitin

  • Coenzyme Q10

  • Curcumin

  • Dong Quai

  • Ginger

  • Green Tea

  • Vitamin A

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of bivalirudin. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bleeding problems, active—Should not be used in patients with this condition.

  • Brachytherapy (a radiation treatment)—Use with caution. Your chance of having blot clots may be increased.

  • Kidney disease—Use with caution. May require an adjustment of dosage for patients with this condition.

Proper Use of bivalirudin


A nurse or other trained health professional will give you bivalirudin. bivalirudin is given through a needle placed into one of your veins.


Precautions While Using bivalirudin


It is very important that your doctor check you at regular visits after you leave the hospital for any problems or unwanted effects that may be caused by bivalirudin. Be sure to keep all appointments.


Bivalirudin may increase your chance of bleeding. Check with your doctor right away if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin. Avoid picking your nose. If you need to blow your nose, blow it gently.


bivalirudin Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Abdominal pain or swelling

  • arm, back, or jaw pain

  • black, tarry stools

  • blood in the eyes

  • blood in the urine

  • blurred vision

  • bruising or purple areas on the skin

  • chest pain or discomfort

  • chest tightness or heaviness

  • confusion

  • coughing up blood

  • decreased alertness

  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly

  • headache

  • joint pain or swelling

  • nausea

  • nervousness

  • nosebleeds

  • pounding in the ears

  • shortness of breath

  • slow, fast, or irregular heartbeat

  • sweating

  • unusual tiredness or weakness

Less common
  • Decrease in frequency of urination

  • decrease in urine volume

  • difficulty in passing urine (dribbling)

  • lightheadedness or fainting

  • painful urination

Rare
  • Blue lips and fingernails

  • changes in skin color

  • cold hands and feet

  • cough or hoarseness

  • coughing that sometimes produces a pink frothy sputum

  • difficult, fast, noisy breathing, sometimes with wheezing

  • fever or chills

  • increased blood pressure

  • increased thirst

  • loss of appetite

  • lower back or side pain

  • pain, redness, or swelling in the arm or leg

  • pale skin

  • paralysis of the face

  • rapid, shallow breathing

  • severe numbness, especially on one side of the face or body

  • swelling in the legs and ankles

  • swelling of the face, fingers, or lower legs

  • troubled breathing

  • vomiting

  • weight gain

Incidence not known
  • Bleeding gums

  • difficulty in swallowing

  • hives

  • increased menstrual flow or vaginal bleeding

  • irritation

  • itching

  • joint stiffness

  • pains in the chest, groin, or legs, especially calves of legs

  • paralysis

  • prolonged bleeding from cuts

  • rash

  • red or dark brown urine

  • redness of the skin

  • severe headaches of sudden onset

  • sudden loss of coordination

  • sudden onset of shortness of breath for no apparent reason

  • sudden onset of slurred speech

  • sudden vision changes

  • swelling of the eyelids, lips, hands, or feet

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Fear or nervousness

  • pain where the needle is placed

  • pelvic pain

  • sleeplessness

  • trouble sleeping

  • unable to sleep

Less common
  • Acid or sour stomach

  • belching

  • heartburn

  • indigestion

  • stomach discomfort, upset, or pain

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: bivalirudin Intravenous side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More bivalirudin Intravenous resources


  • Bivalirudin Intravenous Side Effects (in more detail)
  • Bivalirudin Intravenous Use in Pregnancy & Breastfeeding
  • Bivalirudin Intravenous Drug Interactions
  • Bivalirudin Intravenous Support Group
  • 0 Reviews for Bivalirudin Intravenous - Add your own review/rating


Compare bivalirudin Intravenous with other medications


  • Angina
  • Percutaneous Coronary Intervention